Invention Grant
- Patent Title: Daidzein analogs as treatment for cancer
-
Application No.: US14597252Application Date: 2015-01-15
-
Publication No.: US09669004B2Publication Date: 2017-06-06
- Inventor: Guangdi Wang , Matthew E. Burow , Stephen M. Boue , Thomas E. Wiese , Quan Jiang
- Applicant: THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND , UNITED STATES DEPARTMENT OF AGRICULTURE , XAVIER UNIVERSITY OF LOUISIANA
- Applicant Address: US LA New Orleans US LA New Orleans US LA New Orleans
- Assignee: The Administrators of the Tulane Educational Fund,United States Department of Agriculture,Xavier University of Louisiana
- Current Assignee: The Administrators of the Tulane Educational Fund,United States Department of Agriculture,Xavier University of Louisiana
- Current Assignee Address: US LA New Orleans US LA New Orleans US LA New Orleans
- Agency: McBee Moore Woodward & Vanik IP, LLC
- Main IPC: C07D311/38
- IPC: C07D311/38 ; A61K31/353 ; A61K31/352 ; C07D493/04
Abstract:
Provided are compositions for treatment of cancers, including breast cancer, comprising at least one novel daidzein analog, as well as methods of using the same for preventing or treating cancer or tumor growth.
Public/Granted literature
- US20150148409A1 NOVEL DAIDZEIN ANALOGS AS TREATMENT FOR CANCER Public/Granted day:2015-05-28
Information query
